Overall Technical outlook

Price Summary

Eris Lifesciences Limited's stock opened at 1674.8 on 2025-08-14, surged to 1700.0, hit a low of 1664.0, and closed up 0.58% at 1684.5, with 35807 shares traded.
During the 52-week span, the stock hit a high of 1847.7 and a low of 1153.1.
The projected price range for Eris Lifesciences Limited is between 1680.0 and 2000.0, with an expected mean price of 1860.1, according to 10 analysts.

Technicals

Support and Resistance: The current price of 1684.5 for ERIS finds support at 1683.8 and resistance at 1792.1. These levels define a range in which the price might oscillate, with 1683.8 as a potential support and 1792.1 as a resistance level.
ERIS supportResistance 77457f
Support/Resistance for ERIS


Aroon: The current reading of the AROON indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
ERIS aroon 77457f
Aroon chart for Eris Lifesciences Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
ERIS bbands 77457f
Bolinger Bands chart for Eris Lifesciences Limited


Parabolic SAR: The PSAR remains bearish for Eris Lifesciences Limited, establishing a crucial resistance level that could hinder any bullish attempts. This ongoing bearish outlook suggests that the market may continue to face resistance, making it difficult for prices to rise.
ERIS psar 77457f
Parabolic Stop and Reverse chart for Eris Lifesciences Limited


Stochastic: With the Stochastic K-line below the D-line and under 20, the market shows a mildly bearish trend. This setup suggests possible downward movement, though the bearish sentiment is relatively mild. Traders should keep this in mind and watch for further developments.
ERIS stoch 77457f
Stochastic chart for Eris Lifesciences Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
ERIS trippleSMA 77457f
Tripple SMA chart for Eris Lifesciences Limited


A comprehensive approach to analyzing a company requires considering both its technical and fundamental aspects. The company's fundamentals, such as its earnings, growth prospects, and financial health, provide a strong foundation for understanding technical indicators. Additionally, examining the industry it operates in helps contextualize the company's position within the broader market. By integrating these factors, one can gain more valuable insights into the company's stock performance and potential investment opportunities.